1. Диагностика и лечение артериальной гипертензии. Рекомендации Российского медицинского общества по артериальной гипертонии и Всероссийского научного общества кардиологов. Кардиоваск. тер. и проф. Прил. 2. 2008; 7 (6).
2. Triggle DJ. Mechanisms of action of calcium channel antagonists. In: Calcium antagonists in clinical medicine. Ed. by M.Epstein. Philadelphia, 1998; p. 1-26.
3. Leenen FHH, Fourney A, Notman G, Tanner J. Persistence of antihypertensive effect after missed doses of calcium antagonist with long (amlodipine) vs short (diltiazem) harf-life. Br J Clin Pharmacol 1996; 41: 83-8.
4. Zannad F, Bernaud CM, Fay R. Double-blind, randomized, multicentre comparison of the effects of amlodipine and perindopril on 24h therapeutic coverage and beyond in patients with mild to moderate hypertension. J Hyperten 1999; 17: 137-46.
5. http://www.docguide.com
6. Toyo-Oka T, Nayler WG. Third generation calcium entry blockers. Blood Pressure 1996; 5: 206-8.
7. Siche JP et al. Effects of amlodipine on baroreflex and sympathetic nervous system activity in mild-to-moderate hypertension. Am J Hypertens 2001; 14 (5 Pt 1): 424-8.
8. Susaguri M et al. Amlodipine lowers blood pressure without increasing sympathetic activity or activating the rennin-angiotensin system in patients with essential hypertension. Eur J Clin Pharmacol 1997; 53 (3-4): 197-201.
9. Фельдшерова Н.А., Семернин Е.Н. Амлодипин: обзор клинических исследований. Кач. клинич. практ. 2002; 2: 27-33.
10. Neaton JD, Grimm RH, Prineas RJ et al. Treatment of Mild Hypertension Study: final results. JAMA 1993; 270: 713-24.
11. Dahlof B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients. A meta analysis of 109 treatment studies. Am J Hypertens 1992; 5: 95-110.
12. Islim IF, Watson RD, Ihenacho HNC et al. Amlodipine: Effective for treatment of Mild to Moderate Essential Hypertension and Left Ventricular Hypertrophy. Cardiology 2001; 96: 10-8.
13. The ALLHAT officers and coordinators for the ALLHAT collaborative research group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: The Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT). JAMA 2000; 283: 1967-75.
14. Pitt B et al. Effect of amlodipine on progression of atherosclerosis and the occurrence of clinical events. PREVENT investigators. Circulation 2000; 102 (13): 1503-10.
15. Nissen S, Tuzcu E, Libby P et al. Effects of antihypertensive drugs on cardiovascular events in patients with coronary heart disease and normal blood pressure. Randomized controlled CAMELOT study. JAMA 2004; 292 (18): 2217-26.
16. Dahlof B, Sever PS, Poulter NR et al. Prevention of cardiovascular events with an Antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendrofluazide as required, in Anglo-Scandinavian Cardiac Outcomes Trial Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomized controlled trial. Lancet 2005; 366: 895-906.
17. Sever PS, Dahlof B, Poultier NR et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): multicentre randomised controlled trial. Lancet 2003; 361: 1149-58.
18. Преображенский Д.В., Сидоренко Б.А., Шабаева Е.Н. Амлодипин - антагонист кальция III поколения. Кардиология. 1998; 2: 66-73.
19. Белоусов Ю.Б., Леонова М.В. Антагонисты кальция пролонгированного действия и сердечно-сосудистая заболеваемость: Новые данные доказательной медицины. Кардиология. 2001; 4: 87-93
20. Jorgensen B, Thaulow E. Effects of amlodipine on ischemia after percutaneuos transluminal coronary angioplasty: Secondary results of the Coronary Angioplasty Amlodipine Restenosis (CAPARES) study. Am Heart J 2003; 145: 1030-5.
21. http://www.lvrach.ru
22. Packer M, O'Connor C, Ghali J et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. New Engl J Med 1996; 335: 1107-14.
23. Ушкалова Е.А. Фармакологические свойства амлодипина - антагониста кальция последнего поколения. Кардиология. 2004; 14: 91.
24. Терещенко С.Н., Жиров И.В. Место амлодипина в лечении хронической сердечной недостаточности у женщин. Пробл. женск. здор. 2007; 2 (4): 17-22.
25. Чазова И.Е., Ратова Л.Г. Лечение артериальной гипертонии у больных с метаболическим синдромом. Системные гипертензии. 2008; 1: 39-43.
Послать статью по эл. почте 